Fractional CO2 laser is an effective therapeutic modality for xanthelasma palpebrarum: a randomized clinical trial.
BACKGROUND
Xanthelasma palpebrarum (XP) is a common cosmetic concern. Although there is a wide range of therapeutic modalities for XP, there is no general consensus on the optimal treatment for such condition.


OBJECTIVE
Compare the efficacy and safety of super pulsed (SP) and fractional CO2 lasers in the treatment of XP.


METHODS
This prospective randomized comparative clinical study included 20 adult patients with bilateral and symmetrical XP lesions. Xanthelasma palpebrarum lesions were randomly assigned to treatment by either single session of ablative SP CO2 laser or 3 to 5 sessions of ablative fractional CO2 laser with monthly intervals. All patients were assessed using digital photography and optical coherence tomography images.


RESULTS
Xanthelasma palpebrarum lesions on both sides were successfully removed with significant improvement in size, color, and thickness. Although lesions treated by SP CO2 laser showed significantly better improvement regarding color and thickness of the lesions, downtime and patient satisfaction were significantly better for lesions treated with fractional CO2 laser. Scarring and recurrence were significantly higher in lesions treated by SP CO2 laser.


CONCLUSIONS
Ablative fractional CO2 laser is an effective and safe therapeutic option for XP with significantly shorter downtime and higher patient satisfaction compared with SP CO2 laser.
*All the authors are affiliated with the Department of Dermatology, Kasr El Aini Hospital, Cairo University, Cairo, Egypt.
Samia M
SM
Esmat
Amany Z
AZ
Elramly
Dalia M
DM
Abdel Halim
Heba I
HI
Gawdat
Hanaa I
HI
Taha
D000328:Adult; D000368:Aged; D002245:Carbon Dioxide; D005141:Eyelid Diseases / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D054020:Lasers, Gas / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D017060:Patient Satisfaction; D011446:Prospective Studies; D016896:Treatment Outcome; D014973:Xanthomatosis / Q000532:radiotherapy*
D002245:Carbon Dioxide